A prospective randomized study comparing electrochemically deposited hydroxyapatite and plasma-sprayed hydroxyapatite on titanium stems: 55 hips followed for 2 years with RSA and DXA by Bøe, Berte Grimsmo et al.
Acta Orthopaedica 2011; 82 (1): 13–19  13
A prospective randomized study comparing electro-
chemically deposited hydroxyapatite and plasma-sprayed 
hydroxyapatite on titanium stems
55 hips followed for 2 years with RSA and DXA
Berte Grimsmo Bøe1,2, Stephan M Röhrl1, Tore Heier3, Finnur Snorrason1, and Lars Nordsletten1,2
1Department of Orthopaedics, Oslo University Hospital, Ullevål; 2Faculty of Medicine, University of Oslo; and 3Department of Surgery, Diakonhjemmet 
Hospital, Oslo, Norway
Correspondence BB: berte2@mac.com  
Submitted 10-03-08. Accepted 10-07-15
Open Access - This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, 
distribution, and reproduction in any medium, provided the source is credited.
DOI 10.3109/17453674.2010.548027
Background and purpose   Plasma-sprayed hydroxyapatite (HA) 
is a successful coating for fixation of uncemented femoral stems. 
There may be alternative coatings with advantages in bone remod-
eling and transport of bone-active substances. We investigated 
whether an electrochemically deposited hydroxyapatite, Bone-
master (BM), might be a safe alternative in total hip arthroplasty. 
Our hypothesis was that the new coating would not be inferior to 
the conventional one.
Patients and methods   50 patients (55 hips) were included. The 
stem was tapered and porous-coated proximally. On top of the 
porous coating was either HA or BM. Patients were evaluated 
postoperatively and after 3, 6, 12, and 24 months to measure fixa-
tion by radiostereometric analysis (RSA), bone mineral density 
by dual-energy X-ray absorptiometry (DXA), and conventional 
radiography. Clinical evaluation was performed with Harris hip 
score and Oxford hip score, both preoperatively and after 2 years.
Results   After 2 years, the stems had subsided 0.25 (HA) and 
0.28 (BM) mm and there were no statistically significant differ-
ences between the groups in any direction, regarding both migra-
tion and rotation. The BM group retained significantly more bone 
than the HA group in Gruen zone 1 during the first 2 years. The 
Harris and Oxford hip scores were similar in both groups.
Interpretation   Electrochemically deposited hydroxyapatite on 
an uncemented stem does not appear to be inferior to plasma-
sprayed HA regarding clinical and radiological results, bone 
remodeling, and micromotion after 2 years follow-up.
 
Aseptic loosening is the most frequent complication of total 
hip arthroplasty (THA) (Havelin et al. 2000). The long-term 
survival is thought to depend partly on bone loss or osteol-
ysis in the proximal femur after insertion. Plasma-sprayed 
hydroxyapatite (HA) coatings appear to give effective fixation 
in the femur (Hallan et al. 2007). Alternative coatings may, 
however, influence bone remodeling around the prosthesis and 
may function as a carrier of bone-active substances. 
Bonemaster (BM) (Bonemaster is a registered trademark of   
Biomet Europe) is an electrochemically deposited hydroxy-
apatite (EDHA) coating (Rößler et al. 2002). This technique 
makes it possible to add biological substrates such as antibiot-
ics or adhesion peptides to the coating and still keep the coat-
ing very thin compared to plasma-sprayed HA.
The thickness of a hydroxyapatite coating is a compro-
mise between the mechanical properties and dissolution of 
the coating. A thinner coating minimizes the potential of par-
ticle shedding during insertion. Fewer particles in the joint 
mean less third-body wear and less periprosthetic osteolysis 
(Peters et al. 1992, Shanbhag et al. 1994, Campbell et al. 1995, 
  McKellop et al. 1995). Thinner coatings also lower the risk of 
HA delamination and preserve the porosity of the underlying 
metallic coating of the implant. The irregular implant surface 
increases the surface area, providing a greater contact and 
ingrowth area (Sewing et al. 2002). EDHA, as in Bonemaster, 
forms a needle-like porous structure (Rößler et al. 2001) and 
enhances early-stage fixation between implant and bone (Ban 
et al. 1997).
We designed a prospective randomized trial to compare con-
ventional plasma-sprayed HA with electrochemically depos-
ited HA after insertion of an uncemented femoral stem. This is 
the first clinical trial with the Bonemaster coating. We hypoth-
esized that implants with Bonemaster would achieve the same 
degree of stability and bone remodeling, and the same clinical 
outcome as implants with traditionally plasma-sprayed HA.14  Acta Orthopaedica 2011; 82 (1): 13–19
Patients and methods
50 patients (31 of whom were women; 55 hips) with nonin-
flammatory end-stage osteoarthritis of the hip participated. 
Inclusion criteria were health condition expected to allow 
follow-up for 10 years and anatomy compatible with use of 
a standard implant. Exclusion criteria were infection, revi-
sion arthroplasty, marked bone loss, and severe morbidity. 
Mean age at the time of operation was 63 (27–81) years. 
From December 2003 through June 2005, patients underwent 
THA with the Taperloc uncemented stem (Figure 1), a 28-mm 
cobalt-chrome modular head and the SHP cemented cup. (The 
stems were manufactured by Biomet UK Healthcare Ltd.; all 
other components were from Biomet, Warsaw, IN). Both hips 
of 5 patients were included. Recruitment was by informed 
consent and the patients were on our waiting list for THA. The 
Norwegian Data Inspectorate and the regional ethical commit-
tee approved the study and it was carried out in line with the 
Helsinki declaration.
The patients were randomized (with sealed envelopes) to a 
stem with either plasma-sprayed HA or Bonemaster. 31 hips 
were operated with BM-coated stems and 24 with plasma-
sprayed HA-coated stems. After a power analysis performed 
during the study, we ended the inclusion after recruiting 55 
hips, leaving 45 envelopes unopened. 1 patient was excluded 
because of a periprosthetic fracture. 2 patients have subse-
quently been revised because of loose cups. These 2 patients 
have been followed with measurements of the stem after their 
revisions. 1 patient was reoperated after 5 weeks with soft 
tissue revision and change of femoral head because of infec-
tion, but was kept in the study. 
4 orthopedic consultants in 2 hospitals operated the patients 
using the modified Hardinge approach.
The Taperloc stem was manufactured from forged tita-
nium alloy, Ti-6Al-4V. It had a tapered form and was porous-
coated proximally. On top of the porous coating, the stem 
was coated with either plasma-sprayed HA or electrochemi-
cally deposited hydroxyapatite (BM). Plasma spraying of HA 
is a high-temperature process designed to deliver slightly 
molten Ca(PO4)2 granules of μm size onto metal surfaces. 
The process was first described by de Groot et al. (1987). The 
specifications for the implants in this study were according to 
the manufacturer: 50-micron thick HA coating (Ca/P ratio: 
1.67), a mean surface roughness of 41 microns, a maximum 
roughness depth of 445 microns, and 62% crystallinity. The 
electrochemically deposited hydroxyapatite coating was per-
formed in an electrolyte solution near physiological condi-
tions (pH 6.4, 37°C), consisting of 1.67 mM CaCl2 and 1 mM 
NH4(H2PO4) in equal volumes with the implant polarized in 
cathode galvanostatic mode (–75 A/m2). The layer consisted 
of 70–72% crystalline HA with the balance being amorphous, 
and with a thickness of 5 μm and a Ca/P ratio of 2.0. The 
time taken to apply this form of HA coating is much slower 
than that of HA applied by plasma spray, and is typically 
75 min per implant. Details of preparations, characteristics, 
and appearances of coatings are as described by Rößler et al. 
(2002) and Sewing et al. (2004).
On the acetabular side, we used SHP—an all-poly gamma-
irradiated (ArCom) cemented cup—inserted with Palacos 
(Schering-Plough) gentamycin-containing cement.
Bone mineral density (BMD) was measured by experienced 
technicians using DXA. 3 different DXA machines were used 
(Prodigy and Expert; both from Lunar, Madison, WI—and 
Hologic QDR; Hologic Inc., Bedford, MA). The patient was 
placed supine on the scan table with a foot support to achieve 
standard rotation of the hip. Orthopedic software (Lunar ver-
sion 1.2 and Hologic QDR version 12.3) was used to analyze 
periprosthetic BMD in 7 regions of interest (ROIs). The ROIs 
were based on the Gruen zones. The patients were measured 
within a few days postoperatively (mean 5.8 days) and after 3, 
6, 12, and 24 months. 30 patients treated at “hospital A” were 
measured with a Lunar Expert densitometer until January 1, 
2005 and later with a Hologic densitometer. 25 patients treated 
at “hospital B” were measured with a Lunar Prodigy densitom-
eter. We calculated a transformation formula between Lunar 
Expert and Hologic values based on measurements from 5 of 
the patients included. These 5 patients were measured twice 
on both densitometers, and on the same day. Assuming linear-
ity between the 2 machines, the best fit was found using the 
formula BMDLunar = 0.789 × (BMDHologic) + 0.2089. Because 
this transformation of values represents a bias in the patient 
group from hospital A, we performed statistical analysis on 
the total number of patients, and on the patients from hospital 
B separately.
To calculate precision error (the coefficient of variation, 
CV%) of the 3 densitometers, 130 examinations were repeated 
on the same day, with repositioning between the scans (Table 1). 
Figure 1. Taperloc stem coated 
with Bonemaster.Acta Orthopaedica 2011; 82 (1): 13–19  15
RSA
During the operation 7-8 tantalum markers of 1.0 mm were 
inserted into the proximal part of the femur. The manufacturer 
had attached 3 tantalum markers to the femoral stem, 1 to the 
shoulder, 1 to the neck and 1 to the tip. We also computed 
the position of the femoral head centre. Radiostereometric 
examinations were done at approximately 7 days, 3 months, 6 
months, 1 year, and 2 years after the operation. We evaluated 
migration of the gravitational centre of the segment which 
was defined by the stem markers and the centre of the femo-
Table 1. Coefficient of variation (CV) in per cent for the 3 densiom-
eters used in 7 Gruen zones 
Zone:  1  2 3 4 5  6  7
Expert  2.0   1.5   2.0   1.4   2.3   2.3   2.8 
Hologic  0.5   5.8   1.5   0.6   1.5   1.1   0.8 
Prodigy  2.6   2.1   1.7   3.6   2.2   5.1   2.9
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Figure 2. Flow chart of the patients with DXA and RSA measurements. The patient lost 
to follow-up had an HA-coated stem inserted at hospital A. 17 BM-coated stems were 
inserted at hospital A and 14 BM-coated stems were inserted at hospital B. 13 HA-
coated stems were inserted at hospital A and 11 HA-coated stems were inserted at 
hospital B. Those patients who were not analyzed by RSA did not meet the criteria of a 
maximum condition number of 100 or mean error of less than 0.3.
ral head. Migration was measured along the 
cardinal axes. Stem rotations were measured 
as rotations of that segment around the same 
axes. Analyses were performed using UmRSA 
(Digital measurement 6.0 RSA Biomedical, 
Umeå, Sweden). In 4 cases the quality of 
the postoperative stereoradiographs did not 
allow a proper evaluation. 1 patient was lost 
to follow up, 2 did not meet and 1 patient was 
excluded from the 2 years analysis because 
of high condition number. 47 patients were to 
be analyzed at 2 years with mean error below 
0.3 and condition number below 100 (Figure 
2). 83 examinations were repeated the same 
day to calculate the precision of our measure-
ments. RSA results are presented as mean 
values with standard error of mean (SEM).
Conventional radiography
Anteroposterior and lateral examinations were 
done preoperatively, postoperatively, and after 
3, 6, 12, and 24 months. 2 surgeons evaluated 
the radiographs. The parameters registered 
were implant position, radiolucency or lysis, 
calcar resorption, heterotopic bone formation, 
trabecular remodeling, cyst formation, pedes-
tal formation, and visible migration. Radio-
lucent lines were considered to be present if 
they were > 1.0 mm and occupied more than 
50% of the interface in each Gruen zone.
Clinical evaluation
Harris hip score (Harris 1969) and Oxford hip 
score (Dawson et al. 1996) were evaluated 
preoperatively and after 2 years.
Statistics
The statistical analysis of BMD and RSA 
results to compare Bonemaster to HA was 
done using non-inferiority testing comparing 
areas (SPSS for Mac version PASW 18.0). 
The BMD results were expressed as percent-
ages (mean) with standard deviation (SD). 
RSA results were signed values (mean) with 16  Acta Orthopaedica 2011; 82 (1): 13–19
SEM. The DXA and RSA results were not normally distrib-
uted. The 2 groups were compared with the Mann-Whitney 
U-test. Changes in DXA, postoperatively to the 2-year follow-
up, were analyzed with Wilcoxon signed rank test.
A power analysis was not performed before the study 
started. Based on an estimated clinically important difference 
in BMD of 10% (SD 10), stem migration of 0.6 mm (SD 0.6), 
and stem rotation of 0.7 degrees (SD 0.7) between groups, 
the sample size calculation indicated 17 patients would be 
required in each group to achieve 80% power at the 0.05 sig-
nificance level. Due to the risk of patient dropout, at least 24 
patients were included in each group.
Results
DXA
After 2 years, there was bone loss compared to the postop-
erative values in both groups in all regions around the stem 
(p < 0.05), which was most pronounced in Gruen zones 1 and 
7 (Table 2). With non-inferiority testing between the 2 groups, 
we had to reject the null hypothesis (that Taperloc would func-
tion equally well with Bonemaster and HA) for zone 1. Com-
parison of the areas under the graph showed a significant dif-
ference between HA and BM in zone 1 after 2 years (p = 0.01). 
The bone loss was less in the Bonemaster group. Because of 
the possible bias with the transformation formula used in hos-
pital A, we also performed the analyses with the results from 
hospital B alone. We found the same as for the whole group: 
rejection of the null hypothesis in zone 1 (p = 0.01). For all 
other Gruen zones, the null hypothesis was retained.
RSA
The precision of our measurements was 0.11 mm for subsid-
ence and 0.66 degrees for retroversion. The migration pat-
tern for both stems showed that they moved during the first 
3 months after surgery and then stabilized (Figures 3 and 4). 
The mean (SD) subsidence for the center of the stem after 2 
years was 0.28 (0.47) mm for BM and 0.25 (0.69) mm for 
HA (Figure 3). The stems with Bonemaster moved mean 0.46 
(0.73) degrees in retroversion compared to 0.17 (0.83) degrees 
for the HA-coated stems (p = 0.2) (Figure 4). Both groups had 
retroversion that was lower than the precision in this direction 
(0.66). With non-inferiority testing, there were no significant 
differences between groups in any migration or rotation after 
2 years. 
Clinical results
Harris hip score increased from 55 (pain score 20) 
preoperatively to 95 (pain score 41) after 2 years in the Bone-
master group, which was almost similar to the increase from 
52 (18) to 89 (38) in the HA group. Oxford hip score improved 
from 39 preoperatively to 16 after 2 years in the BM group and 
from 35 to 19 in the HA group. The differences after 2 years 
were not statistically significant.
There were no radiolucent lines around the stems after 2 
years. 1 patient was excluded because of a periprosthetic frac-
ture 6 weeks after the operation. 2 patients in the BM group 
were revised after 10 and 13 months because of cup loosening. 
They were both revised because of pain, and we continued to 
follow the femoral component in the study. Another patient (in 
the BM group) had a postoperative infection and was revised 
with soft tissue debridement and irrigation. Treatment of the 
infection was successful and the patient continued in the study.
RSA and BMD results were analyzed both with and without 
the reoperated patients included, with no significant changes 
in the results. 
Table 2. Periprosthetic changes in bone mineral density around hydroxyapatite- (HA-) and 
Bonemaster- (BM-) coated Taperloc stems measured by dual-energy X-ray absorbtiometry 
(DXA). Results are given in percentage (standard deviation) of postoperative values after 3 
months, 6 months, 1 year, and 2 years 
Gruen zone  n  3 months  n  6 months  n  1 year  n  2 year
1  Bonemaster  30  92 (19)  29  94 (25)  31  90 (26)  30  87 (19)
  HA  20  83 (14)  22  79 (13)  22  76 (15)  22  79 (18)
2  Bonemaster  30  89 (10)  29  92 (8)  31  90 (10)  30  87 (14)
  HA  20  90 (10)  22  90 (8)  22  89 (9)  22  86 (10)
3  Bonemaster  30  93 (7)  29  96 (6)  31  94 (8)  30  90 (12)
  HA  20  94 (5)  22  96 (5)  22  95 (7)  22  92 (9)
4  Bonemaster  30  95 (5)  29  95 (6)  31  94 (5)  30  90 (9)
  HA  20  96 (5)  22  95 (4)  22  94 (6)  22  90 (7)
5  Bonemaster  30  94 (7)  29  97 (7)  31  96 (9)  30  90 (11)
  HA  20  97 (5)  22  97 (6)  22  93 (10)  22  88 (12)
6  Bonemaster  30  93 (9)  29  94 (8)  31  94 (9)  30  89 (11)
  HA  20  94 (7)  22  86 (23)  22  90 (10)  22  88 (9)
7  Bonemaster  30  82 (13)  29  77 (14)  31  73 (15)  30  70 (16)
  HA  20  83 (9)  22  77 (11)  22  73 (12)  22  69 (13)Acta Orthopaedica 2011; 82 (1): 13–19  17
Discussion
Our study was started as a safety study of a new electro-
chemically deposited HA coating. The null hypothesis was 
that Taperloc would function equally well with Bonemaster 
and HA. Our results show that Bonemaster-coated stems do 
not function in an inferior way to stems coated with plasma-
sprayed HA after 2 years.
The most recent publication for the Taperloc stem without 
any HA coating (McLaughlin and Lee 2008) describes good 
long-term results for aseptic loosening with 87% survival after 
20 years. The Taperloc is therefore a good stem for safety 
studies of new technology.
We already knew that HA coating of a porous surface is an 
excellent fixation method. Both Karrholm et al. (1994) and 
Soballe et al. (1993) showed that there is less subsidence with 
HA-coated stems than with porous-coated stems. The ques-
tion is therefore “do we need Bonemaster?”. The total number 
of cementless procedures has increased in recent years. A ben-
efit of a coating placed on the stem by galvanic electrolysis 
is that it can act as a carrier for other substrates. Infections 
remain a critical issue in total joint arthroplasty. Antibiotics 
added to the coating would probably lower the infection rate. 
Alt et al. (2006) demonstrated a lower infection rate in a com-
bined gentamicin-HA group than in an ordinary HA group in 
a rabbit model. 
Osteolysis and bone loss may lead to loosening of the implant 
or periprosthetic fractures. We suggest that some of the proxi-
mal bone loss is due to the surgical trauma from cutting of the 
neck and preparing the proximal femur to receive the prosthe-
sis. We found less reduction in bone density in the Bonemaster 
group than in the HA group in Gruen zone 1 during the first 2 
years. We found no difference in zones 2, 6, and 7, which are 
also regions with BM coating. Perhaps the initial difference 
between the 2 groups was detected in zone 1 because this is 
an area dominated by trabecular bone. Higher bone density 
values in the Bonemaster group may indicate a higher degree 
of bone turnover in trabecular bone in this group. An expected 
result of DXA measurements after implantation of a hip pros-
thesis is a marked bone loss initially, and then restoration of 
bone (Trevisan et al. 1997, Wixson et al. 1997, Karachalios et 
al. 2004). We have not seen any restoration of bone around the 
Taperloc stem during the first two years, but bone loss from 
7% (zone 3) to 31% (zone 7) is acceptable compared to other 
stems. It remains to be seen whether the bone loss would con-
tinue. For prostheses with satisfactory results, the bone loss 
is often limited to the proximal zones. In patients with early 
aseptic loosening, a different pattern of bone remodeling with 
reduction along the entire stem has been found (Boden et 
al. 2004). Scott and Jaffe (1996) predicted that higher BMD 
indicates better ingrowth of bone to the implant. In that case, 
Bonemaster leads to faster bone ingrowth than HA. This was 
not reflected by better stability early on, however, as measured 
by RSA. In an animal study with mechanical pull-out testing, 
Yang et al. (2008) showed that roughened titanium implants 
had better initial fixation to bone when they were coated with 
electrochemically deposited HA than when they only had 
roughened titanium on the surface. 
Another experimental study has shown that plasma-sprayed 
HA accelerates the early-stage mineralization (< 7 days) of 
bone more than EDHA coating (Wang et al. 2006). However, 
EDHA appeared to have resulted in better mechanical inte-
gration between the coating and mineralized tissue. Plasma-
sprayed HA and EDHA were indistinguishable later (14 days) 
regarding the mineralized tissue ratio and microstructure they 
induced in vivo. 
Results for the patients measured on the same DXA machine 
during the entire study were the same as for the whole group. 
Figure 4. Retroversion of hydroxyapatite- (HA-) and Bonemaster- (BM-) 
coated Taperloc stems after 2 years, analyzed by radiostereometric 
analysis. Results are in degrees with standard error of the mean. 
Figure 3. Subsidence (0.25 (HA) and 0.28 (BM) mm in the first 2 
years) after implantation of hydroxyapatite- (HA-) and Bonemaster- 
(BM-) coated Taperloc stems, analyzed by radiostereometric analysis 
(RSA). Results are given in mm with standard error of the mean after 3 
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We therefore consider the values to be reliable for comparison, 
although a change of DXA machine at one institution compli-
cated calculation of bone remodeling.
The amount of acceptable subsidence probably varies 
between different stem designs and fixation methods. Kar-
rholm et al. (1994) showed that the amount of subsidence after 
2 years was the best predictor of later revisions in cemented 
stems. The cut-off values for the probability of revision to 
exceed 50% and 95% were 1.2 mm and 2.6 mm of subsid-
ence after 2 years. In a study with HP-Garche uncemented 
stems, Wykman et al. (1988) reported 0.6–3.9 mm of subsid-
ence in 7 of 8 stems after 2 years. In a later report, the same 
group reported that 13 of 78 HP-Garche stems (17%) had to be 
revised in less than four years (Wykman et al. 1991). 
Wykman and Lundberg (Wykman and Lundberg 1992) pre-
sented an RSA study of 9 patients with porous-coated Taper-
loc stems. 3 stems had subsided 0.7–0.9 mm after 2 years, and 
the mean subsidence after 2 years was 0.44 mm. Compared to 
earlier studies our results thus indicate that concerning subsid-
ence, HA coating of the Taperloc stem is beneficial.
In our trial, the stem subsided in the three first months 
postoperatively and then stabilized. This migration pattern 
has also been shown with other HA-coated implants. Thien 
et al. (2007) published the same pattern of subsidence for 43 
ABG stems. For the clinically proven Corail stem, Campbell 
et al. (2009) documented more subsidence (0.58 mm) than 
for Taperloc over the first 2 years, using RSA analysis. Corail 
had the same migration pattern, however, with stability after 
6 months. As both Corail and Taperloc have good long-term 
clinical results (Hallan et al. 2007), it appears that subsidence 
during the first months and then stabilization within a year is 
typical for these designs of HA-coated uncemented implants. 
This might be explained by the ability of hydroxyapatite to 
close the gap between bone and implant (Overgaard et al. 
1997). Long-term follow-up will be necessary to evaluate the 
effect of electrochemically applied HA on long-term fixation. 
Further studies are required to investigate whether electro-
chemically deposited HA combined with antibiotics might 
lower the infection rate. 
In conclusion, the Taperloc stem with Bonemaster does not 
appear to be inferior to the Taperloc stem with plasma-sprayed 
HA, concerning clinical and radiological results, bone remod-
eling, and micromotion—at least up to 2 years.
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